Audit 370067

FY End
2024-12-31
Total Expended
$262.36M
Findings
0
Programs
84
Year: 2024 Accepted: 2025-09-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
84.268 Federal Direct Student Loans $6.84M Yes 0
93.351 Research Infrastructure Programs $3.52M Yes 0
93.RD Covid-19 - National Institute of Allergy and Infectious Diseases - A Multicenter Platform Trial of Putative Therapeutics for the Treatment of Covid-19 in Hospitalized Adults $2.64M Yes 0
93.398 Cancer Research Manpower $1.53M Yes 0
93.926 Healthy Start Initiative $1.32M Yes 0
93.RD Hispanic Community Health Study - Study of Latinos (hchs-Sol) Field Center $1.27M Yes 0
93.121 Oral Diseases and Disorders Research $932,149 Yes 0
93.822 Health Careers Opportunity Program (hcop) $728,458 Yes 0
93.632 University Centers for Excellence in Developmental Disabilities Education, Research, and Service $599,744 Yes 0
93.838 Lung Diseases Research $280,733 Yes 0
93.RD Hispanic Community Health Study-Study of Latinos (hchs/sol) $259,052 Yes 0
93.RD Development of A Multimodal Antibody Platform to Extend the Window of Immunotherapeutic Intervention $249,473 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $231,368 Yes 0
93.270 Viral Hepatitis Prevention and Control $215,182 Yes 0
93.RD Covid-19 - Innovative Methods to Evaluate the Role of Influenza Vaccines in Attenuating Severe Diseases in Adults $203,700 Yes 0
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $175,219 Yes 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $147,324 Yes 0
12.RD In Vitro Neutralization Testing of Marburg Virus Antibodies with Marv Gp-Pseudotyped Vesicular Stomatitus Virus $133,731 Yes 0
93.866 Aging Research $126,266 Yes 0
93.RD Hispanic Community Health Study - Study of Latinos Research Supplements to Promote Diversity in Health Related Research $121,909 Yes 0
93.RD Covid-19 - National Institute of Allergy and Infectious Diseases - A Multicenter A Multicenter Platform of Putative Therapeutics for the Treatment of Covid-19 in Hospitalized Adults (bets) $121,765 Yes 0
93.865 Child Health and Human Development Extramural Research $114,429 Yes 0
93.068 Chronic Diseases: Research, Control, and Prevention $96,900 Yes 0
93.RD Ovaprene $91,594 Yes 0
93.394 Cancer Detection and Diagnosis Research $70,535 Yes 0
93.867 Vision Research $69,373 Yes 0
84.033 Federal Work-Study Program $63,226 Yes 0
93.213 Research and Training in Complementary and Integrative Health $62,436 Yes 0
93.279 Drug Use and Addiction Research Programs $61,834 Yes 0
93.RD Healthy and Livable Bronx Partnership $61,219 Yes 0
93.225 National Research Service Awards Health Services Research Training $60,427 Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $59,325 Yes 0
12.420 Military Medical Research and Development $58,687 Yes 0
47.076 Stem Education (formerly Education and Human Resources) $52,530 Yes 0
93.310 Trans-Nih Research Support $48,033 Yes 0
93.395 Cancer Treatment Research $46,756 Yes 0
93.137 Community Programs to Improve Minority Health $43,880 Yes 0
12.RD Development of Pan-Arenavirus Nanobody Therapeutics $40,546 Yes 0
93.396 Cancer Biology Research $33,067 Yes 0
93.172 Human Genome Research $29,378 Yes 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $28,136 Yes 0
93.855 Allergy and Infectious Diseases Research $27,108 Yes 0
93.173 Research Related to Deafness and Communication Disorders $26,313 Yes 0
93.839 Blood Diseases and Resources Research $25,840 Yes 0
93.273 Alcohol Research Programs $24,196 Yes 0
93.233 National Center on Sleep Disorders Research $21,962 Yes 0
93.RD A Point-of-Care Digital Microfluidic Platform for Diagnosis of Viremic Hepatitis C Infection and Confirmation of Cure Following Treatment $21,022 Yes 0
93.RD Hispanic Community Health Study - Study of Latinos $20,606 Yes 0
93.RD Contraceptive Development Program Nichd Contraceptive Clinical Trials Network-Female Sites $19,843 Yes 0
93.393 Cancer Cause and Prevention Research $19,563 Yes 0
47.074 Biological Sciences $15,864 Yes 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $14,574 Yes 0
93.145 Hiv-Related Training and Technical Assistance $14,558 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $12,772 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $11,436 Yes 0
93.399 Cancer Control $10,530 Yes 0
10.310 Agriculture and Food Research Initiative (afri) $7,712 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $7,335 Yes 0
93.899 Minority Hiv/aids Fund (mhaf) $7,279 Yes 0
93.859 Biomedical Research and Research Training $5,897 Yes 0
93.083 Prevention of Disease, Disability, and Death Through Immunization and Control of Respiratory and Related Diseases $4,105 Yes 0
93.RD A Randomized, Double-Blind Evaluation of Crs3123 Versus Oral Vancomycin in Adult Patients with Clostridioides Difficile Infection $3,800 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $3,647 Yes 0
93.113 Environmental Health $3,463 Yes 0
93.103 Food and Drug Administration Research $3,245 Yes 0
93.837 Cardiovascular Diseases Research $2,100 Yes 0
93.RD National Cancer Institute (nci) - Lmi-001-A, Nci Cervical Cancer 'last Mile' Initiative 'self-Collection for Hpv Testing to Improve Cervical Cancer Prevention' (ship) Trial $2,048 Yes 0
93.RD Covid-19 - Hispanic Community Health Study-Study of Latinos (hchs/sol) $1,480 Yes 0
93.350 National Center for Advancing Translational Sciences $374 Yes 0
93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance $165 Yes 0
93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance $70 Yes 0
93.262 Occupational Safety and Health Program $27 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $19 Yes 0
93.242 Mental Health Research Grants $-3 Yes 0
12.RD Afrl/rgv 21.1b Small Business Innovation Research (sbir) Phase II $-4 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $-10 Yes 0
84.425 Education Stabilization Fund $-68 Yes 0
93.250 Geriatric Academic Career Awards Department of Health and Human Services $-81 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $-344 Yes 0
93.397 Cancer Centers Support Grants $-5,499 Yes 0
93.307 Minority Health and Health Disparities Research $-6,508 Yes 0
84.425E Cares Act: Higher Education Emergency Relief Fund- Student Aid Portion $-7,496 Yes 0
93.RD Covid-19 - A Prospective Randomized Trial of Carbon Ion Versus Conventional Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer $-16,757 Yes 0
93.RD A Prospective Randomized Trial of Carbon Ion Versus Conventional Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer $-151,963 Yes 0

Contacts

Name Title Type
H6N1ZF5HJ2G3 James Geraghty Auditee
7184303255 Michael Dilillo Auditor
No contacts on file

Notes to SEFA

The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Schedule may differ from amounts presented in, or used in the preparation of, the College’s consolidated financial statements. For purposes of the Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts, cooperative agreements, loan and loan guarantees, or other non-cash assistance. Direct and indirect costs are charged to awards in accordance with cost principles contained in the United States Department of Health and Human Services Cost Principles for Hospitals at 45 CFR Part 75 Appendix IX and 45 CFR Part 74 Appendix E, as applicable. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. The Uniform Guidance provides for a 10% de minimis indirect cost rate election; however, the College did not make this election and uses a negotiated indirect cost rate.
Beginning January 1, 2019, the College began participating in the Federal Direct Student Loan Program (Assistance Listing Number 84.268) (which includes the Stafford and GradPlus Loans). The College’s outstanding loan balances related to the program are $51,191 at December 31, 2024. Since this program is administered by the U.S. Department of Education, new loans made in the year ended December 31, 2024 relating to this program are considered current period federal expenditures, whereas the outstanding balances are not. The new loans made in the year ended December 31, 2024 are reported in the Schedule.